From: Spectrophotometric determination of etodolac in pure form and pharmaceutical formulations
Sample | Recoverya ± SD (%) | ||||
---|---|---|---|---|---|
Official method | Proposed methods | ||||
A | B | C | |||
Napilac capsules (200 mg ETD/Capsule) | X ± SD | 99.70 ± 1.16 | 98.52 ± 0.79 | 100.65 ± 1.19 | 100.27 ± 0.92 |
t b | 1.87 | 0.74 | 0.86 | ||
F b | 2.17 | 1.05 | 1.60 | ||
Etodine capsules (300 mg ETD/Capsule) | X ± SD | 100.50 ± 1.36 | 99.95 ± 0.81 | 100.30 ± 0.96 | 100.04 ± 1.02 |
t b | 0.78 | 0.27 | 0.61 | ||
F b | 2.82 | 2.01 | 1.78 |